UNH Stock Chart & Stats
€344.80
€4.40(1.20%)
At close: 4:00 PM EDT
€344.80
€4.40(1.20%)
Day’s Range― - ―
52-Week Range€222.70 - €400.60
Previous CloseN/A
Volume1.35K
Average Volume (3M)802.00
Market Cap
€293.21B
Enterprise Value€457.39K
Total Cash (Recent Filing)€31.47B
Total Debt (Recent Filing)€73.33B
Price to Earnings (P/E)24.2
Beta-0.17
Next Earnings
Oct 13, 2026EPS Estimate
3.57Next Dividend Ex-DateN/A
Dividend Yield2.4%
Share Statistics
EPS (TTM)15.55
Shares Outstanding897,594,850
10 Day Avg. Volume712
30 Day Avg. Volume802
Financial Highlights & Ratios
PEG Ratio-1.62
Price to Book (P/B)3.19
Price to Sales (P/S)0.67
P/FCF Ratio18.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€419.43Price Target Upside21.64% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering22
EPS Forecast (FY)17.24
Revenue Forecast (FY)€388.93B
Bulls Say, Bears Say
Bulls Say
Diversified Healthcare PlatformOperating across insurance, pharmacy, care delivery, and data/technology services diversifies revenue sources and places UNH across multiple parts of the health-care value chain. This breadth can support customer reach, business resilience, and recurring demand as payers seek integrated cost management.
Strong Cash GenerationRobust operating and free cash flow gives UNH meaningful capacity to fund technology, care delivery, dividends, and repurchases while retaining financial flexibility. Healthy free-cash-flow conversion indicates that reported earnings are supported by substantial cash generation rather than only accounting profitability.
Optum Operating ScaleOptum’s broad geographic reach and high pharmacy-client retention indicate established distribution, customer relationships, and operating scale. These attributes can reinforce recurring service revenue and provide a durable platform for expanding analytics, care management, and pharmacy capabilities.
Bears Say
Margin CompressionMaterially lower net and EBIT margins show that revenue growth is not translating into the profitability achieved in earlier years. Persistent cost pressure or an unfavorable mix would reduce earnings resilience, limit operating leverage, and make future profit recovery more dependent on execution.
Commercial Medical Cost PressureMedical costs growing faster than expected can compress underwriting spreads when premiums and reimbursement do not adjust immediately. The stated delay in commercial margin recovery suggests this is more than a single-quarter issue and may constrain profitability over the next several quarters.
Public-program HeadwindsDeclining Medicare Advantage enrollment can reduce membership scale, while negative Medicaid margins directly pressure returns in public-sector businesses. Together, these trends make government-program earnings more difficult to grow and increase reliance on pricing, rate actions, and cost control.
UnitedHealth News
UNH FAQ
What was UnitedHealth’s price range in the past 12 months?
UnitedHealth lowest stock price was €222.70 and its highest was €400.60 in the past 12 months.
What is UnitedHealth’s market cap?
UnitedHealth’s market cap is €293.21B.
When is UnitedHealth’s upcoming earnings report date?
UnitedHealth’s upcoming earnings report date is Oct 13, 2026 which is in 24 days.
How were UnitedHealth’s earnings last quarter?
UnitedHealth released its earnings results on Jul 16, 2026. The company reported €5.532 earnings per share for the quarter, beating the consensus estimate of €4.255 by €1.277.
Is UnitedHealth overvalued?
According to Wall Street analysts UnitedHealth’s price is currently Undervalued.
Does UnitedHealth pay dividends?
UnitedHealth pays a Quarterly dividend of €2.019 which represents an annual dividend yield of 2.4%. See more information on UnitedHealth dividends here
What is UnitedHealth’s EPS estimate?
UnitedHealth’s EPS estimate is 3.57.
How many shares outstanding does UnitedHealth have?
UnitedHealth has 897,594,850 shares outstanding.
What happened to UnitedHealth’s price movement after its last earnings report?
UnitedHealth reported an EPS of €5.532 in its last earnings report, beating expectations of €4.255. Following the earnings report the stock price went up 2.38%.
Which hedge fund is a major shareholder of UnitedHealth?
Currently, no hedge funds are holding shares in DE:UNH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
UnitedHealth Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€419.43 (21.64% Upside)
€419.43 (21.64% Upside)
Blogger Sentiment
Bullish
DE:UNH Sentiment 87%
Sector Average 62%
Sector Average 62%
Insider Transactions
Sold Shares
Worth €569.6K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 91%
Bearish news 9%
Bearish news 9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
15.56%
12-Months-Change
Fundamentals
Return on Equity
2.40%
Trailing 12-Months
Asset Growth
0.37%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
UnitedHealth
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.
UNH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call reflects a broadly positive tone: strong quarter-to-date financial results (notably double-digit EPS growth and raised guidance), solid operational progress across Optum (AI-led efficiency gains, improved care metrics), and meaningful shareholder returns and balance sheet improvement. However, the company faces notable near-term headwinds—elevated commercial medical cost trends, pressured Medicaid margins, Medicare enrollment declines, and some one-time favorable prior-period development—creating areas of ongoing focus and uncertainty. On balance, the positive developments and upgraded outlook outweigh the challenges, but management emphasizes continued urgency and investment to sustain improvement.View all DE:UNH earnings summariesUNH Revenue Breakdown
78.70% Premiums
11.93% Products
8.50% Services
0.88% Investment and other income
UNH Stock 12 Month Forecast
Average Price Target
€419.43
▲(21.64% Upside)